Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality

AIDS Patient Care and STDs

Volumn 17, Issue 9, 2003, Pages 461-469

  Wong, Ka Hing ^a   Lee, Shui Shan ^a,b   Low, Kelvin Hon Kei ^a   Wan, Wai Yee ^a  

^a Special Preventive Programme   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CHILD; CHINESE; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PERSISTENT INFECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIAN CONTINENTAL ANCESTRY GROUP; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HONG KONG; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RISK FACTORS; SEX FACTORS; SEXUAL BEHAVIOR;

EID: 0141483390     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103322395492     Document Type: Article

References (24)

1. Alcabes P, Munoz A, Vlahov D, Friedland GH. Incubation period of human immunodeficiency virus. Epidemiol Rev 1993;15:303-318.
2. Eger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. BMJ 1997;315:1194-1199.
3. Department of Health. Seroprevalence of HIV infection in Hong Kong. Hong Kong STD/AIDS Update 2001;7:13-14.
4. Scientific Committee on AIDS. Classification system for HIV infection and surveillance case definition for AIDS in adolescents and adults in Hong Kong. Hong Kong: Advisory Council on AIDS, 1995.
5. Centers for Disease Control. 1993 Revised Classification System for HIV Infection and Expanded Surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
6. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bi-sexual men: An 11 year follow up study. BMJ 1990; 301:1183-1188.
7. Karon JM, Buehler JW, Byers RH, et al. Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons-United States, 1992-1994. MMWR Recomm Rep 1992;41:1-29.
8. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286: 2568-2577.
9. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood: Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393.
10. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996; 97:710-716.
11. Porter K, Wall PG, Evans BG. Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. BMJ 1993;307:20-23.
12. Poznansky MC, Coker R, Skinner C, et al. HIV positive patients first presenting with an AIDS defining illness: Characteristics and survival. BMJ 1995;311: 156-158.
13. Girardi E, Sampaolesi A, Gentile M, Nurra G, Ippolito G. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr 2000;25:71-76.
14. Belanger F, Meyer L, Carre N, Coutellier A, Deveau C. Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: The SEROCO cohort (1988-1994). The Seroco Study Group. Int J Epidemiol 1997;26:1340-1345.
15. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: A comparison with male homosexuals. Am J Epidemiol 1992;135:428-437.
16. Touloumi G, Hatzakis A, Rosenberg PS, O'Brien TR, Goedert JJ. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study. AIDS 1998;12:1691-1697.
17. Wong KH, Lee SS, Choi MY, Lee CK, Lau YL. Non-progressors of HIV infection-Hong Kong Experience. Int J Infect Dis 1996;1:14-17.
18. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-1189.
19. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
20. Schwarcz SK, Hsu LC, Vittinghoff E, Katz MH. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996. Am J Epidemiol 2000;152:178-185.
21. Couturier E, Schwoebel V, Michon C, et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS 1998;12:795-800.
22. Samet JH, Frredberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: The long-term non-presenter. AIDS 2001;15:77-85.
23. Samet JH, Frredberg KA, Stein MD, et al. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998; 158:734-740.
24. Montgomery JP, Gillespie BW, Gentry AC, Mokotoff ED, Crane LR, James SA. Does access to health care impact survival time after diagnosis of AIDS? AIDS Patient Care STDS 2002;16:223-231.